nimodipine has been researched along with Lung Neoplasms in 2 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Filos, KS | 1 |
| Goudas, LC | 1 |
| Patroni, O | 1 |
| Tassoudis, V | 1 |
| Cattaneo, MG | 1 |
| Gullo, M | 1 |
| Vicentini, LM | 1 |
1 trial available for nimodipine and Lung Neoplasms
| Article | Year |
|---|---|
Analgesia with epidural nimodipine.
Topics: Adult; Aged; Analgesia; Analgesia, Epidural; Breast Neoplasms; Female; Humans; Injections, Intraveno | 1993 |
1 other study available for nimodipine and Lung Neoplasms
| Article | Year |
|---|---|
Ca2+ and Ca2+ channel antagonists in the control of human small cell lung carcinoma cell proliferation.
Topics: Animals; Calcium; Calcium Channel Blockers; Calmodulin; Carcinoma, Small Cell; Cell Division; DNA, N | 1993 |